Advances in the Treatment of Renal Cell Carcinoma
This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_79585 | ||
005 | 20220321 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220321s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-2934-9 | ||
020 | |a 9783036529356 | ||
020 | |a 9783036529349 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-2934-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Reynolds, Paul |4 edt | |
700 | 1 | |a Stewart, Grant D |4 edt | |
700 | 1 | |a Reynolds, Paul |4 oth | |
700 | 1 | |a Stewart, Grant D |4 oth | |
245 | 1 | 0 | |a Advances in the Treatment of Renal Cell Carcinoma |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (221 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a renal cell carcinoma | ||
653 | |a autophagy | ||
653 | |a hydroxychloroquine | ||
653 | |a chloroquine | ||
653 | |a ROC-325 | ||
653 | |a cysteine cathepsins | ||
653 | |a cysteine cathepsin inhibitors | ||
653 | |a lysosome | ||
653 | |a renal cancer | ||
653 | |a metastatic renal cell carcinoma | ||
653 | |a immune-based combination therapies | ||
653 | |a network meta-analysis | ||
653 | |a PD-L1 | ||
653 | |a predictive | ||
653 | |a biomarker | ||
653 | |a treatment | ||
653 | |a TKIs | ||
653 | |a mRCC | ||
653 | |a biomarkers | ||
653 | |a soluble factors | ||
653 | |a immunotherapy | ||
653 | |a renal cell carcinoma (RCC) | ||
653 | |a sunitib resistance | ||
653 | |a artesunate (ART) | ||
653 | |a Traditional Chinese Medicine (TCM) | ||
653 | |a growth inhibition | ||
653 | |a ferroptosis | ||
653 | |a reactive oxygen species (ROS) | ||
653 | |a clear cell renal cell carcinoma | ||
653 | |a ccRCC | ||
653 | |a RCC | ||
653 | |a kidney cancer | ||
653 | |a evolution | ||
653 | |a evolutionary trajectory | ||
653 | |a metastatic | ||
653 | |a second line therapy | ||
653 | |a renal cell cancer | ||
653 | |a immune checkpoint inhibitors | ||
653 | |a tyrosine kinase inhibitors | ||
653 | |a individualization | ||
653 | |a genomic signature | ||
653 | |a transcriptomic analysis | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4966 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/79585 |7 0 |z DOAB: description of the publication |